A B S T R A C T Recent studies have shown that -75% of the nuclear 3,5,3'-triiodothyronine (T3) present in adult rat cerebral cortex (Cx) derives from 5'-deiodination of thyroxine (T4) within this tissue. The activity of iodothyronine 5'-deiodinase (I 5'D), the enzyme catalyzing T4 to T3 conversion, increases rapidly after thyroidectomy, suggesting that this could be a compensatory response to hypothyroxinemia. To evaluate this possibility during the period of central nervous system maturation, we studied several thyroid hormone-responsive enzymes (aspartic transaminase [AT], succinic dehydrogenase [S.D.], and Na/K ATPase) in the Cx of 2-, 3-, and 4-wk-old rats. The rats were made congenitally hypothyroid by placing 1, 2, 5, and 20 mg methimazole (MMI) in 100 ml of the mothers' drinking water from day 16 of gestation throughout the nursing period and to the litters after weaning. In addition, serum thyroid hormones, I 5'D, and, in some experiments, in vivo T4 to T3 conversion in Cx were measured in the same pups. Serum T4 concentrations varied from <1 to 40 ng/ml and were generally inversely related to maternal MMI dose. Serum T3 was less affected by MMI than was T4. At 2 wk, decreases in AT, S.D., and ATPase were present in the 20-mg-MMI group but not in the 5-mg-MMI pups despite low serum T4 (<10 ng/ml) in the latter. At 3 and 4 wk, both 5-and 20-mg-MMI groups had significant reductions in these cortical enzymes despite a normal serum T3 in the 5-mg-MMI rats. Cortical I 5'D activity was 10-fold the control value in 5-and 20-mg-MMI animals at 2 wk but increased only three-to fivefold at 3 and 4 wk. I 5'D correlated inversely with serum T4 (r 2 0.96) at all ages, but the less marked elevation of this enzyme in 3-and 4-wk-old pups was not accompanied by an increase in serum T4. Serum T3 increased or remained the same between 2 and 3 wk. These results suggested that the 10-fold increase in I 5'D at 2 wk protected the 5-mg-MMI group from tissue hypothyroidism, but that the three-to fivefold increase at 3 and 4 wk could not. Injection of -250 ng T4/100 g body weight to 2-wk-old, 20-mg-MMI pups (onesixth the normal T4 production rate) led to both a 1.8-ng/g cortical tissue increment in cortical T3 and a significant increase in AT at 24 h, compared with a 0.38-ng/g cortical tissue T3 increment and no change in AT in euthyroid controls. The larger increment in T3 of the 20-mg-MMI pups was due in great part to increased fractional T4 to T3 conversion. Although the latter resulted in greater serum T3 concentrations, three-fourths of the newly formed T3 in the cortex was generated in situ, and it was blocked by iopanoic acid as was the increase in AT. We conclude that 70-80% of the T3 in the Cx of the neonatal rat is produced locally. Serum T4 appears to serve both as a precursor for T3 and as a critical signal for increases in cortical I 5'D. The increased I 5'D can result in normal or nearnormal cerebrocortical T3 concentrations despite marked reductions in serum T4. This mechanism seems to be particularly effective around 2 wk of age when many thyroid-hormone-dependent maturational changes occur in the rat Cx.
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INTRODUCTION
The concept that thyroid hormones are essential for normal development of the central nervous system (CNS)' is well established (1) . The lack of these hormones during critical periods of CNS maturation induces morphological, physiological, and biochemical abnormalities. The most striking morphological alteration is a reduction in the number of arborizations of the neurons in the cortex of cerebral hemispheres and cerebellum (2) . These perturbations induced by thyroid hormone deficiency are paralleled biochemically by a decrease in the incorporation of glucose-carbon into glutamic acid in the so-called gamma aminobutyric acid shunt (3) . Both aspartic transaminase (AT) and succinic dehydrogenase (S.D.), enzymes involved in these metabolic pathways, are known to be decreased in the brain of neonatal hypothyroid rats (4, 5) , although a number of other enzymes not as closely related to this pathway have also been shown to be reduced (5) .
We have recently found that in situ thyroxine (T4) to triiodothyronine (T3) conversion is the main source of T3 in adult rat brain, accounting for 75 and 60% of the T3 measurable in cerebral cortex (Cx) and cerebellar cell nuclei, respectively (6) . Enzymatic 5'-deiodination of T4 is demonstrable in homogenates of different regions of the brain (7) . Even more interesting is that this enzyme activity has a maturational pattern that suggests that it may be of physiological relevance for the development of the brain (8) , because the activity is increased between 10 and 30 d when most of the changes alluded to above take place (1) (2) (3) (4) (5) . The finding of increased enzyme activity in adult (7, 9, 10) , as well as in neonatal, hypothyroid rat cerebral homogenates (11) further supports that suggestion.
Earlier studies from our laboratory showed that the pituitary T3 content is also heavily dependent on local T4 to T3 conversion (12) . A fall in T4 production resulting from a failing thyroid gland leads to pituitary thyrotropin (thyroid-stimulating hormone [TSH] ) release, and the ensuing thyroid stimulation maintains plasma T3 within normal limits until well advanced thyroid failure (for a review see 13) . Studies of congenitally hypothyroid infants show that the level of serum T3 is often normal, whereas that of T4 and TSH are markedly altered (14) .
It thus seems possible that the ultimate impact that thyroid hormone deficiency may have on brain development depends not only on the extent of the thy- ' Abbreviations used in this paper: AT, aspartic transaminase; bw, body weight; CNS, central nervous system; Cx, cerebral cortex; DTT, dithiothreitol; GA, gestational age; a-GPD, a-glycerophosphate dehydrogenase; INT, iodonitrotetrazolium; IOP, iopanoic acid; I 5'D, iodothyronine 5 '-deiodinase; MMI, methimazole; PTU, propylthiouracil; rT3, reverse T3; S.D., succinic dehydrogenase; TSH, thyrotropin (thyroid-stimulating hormone); T4, thyroxine; T3, triiodothyronine.
roid failure, but also on the success of the various compensatory mechanisms in the pituitary and in the brain itself. Because at birth both the CNS and hypothalamic-pituitary system of the rat are less mature than those in the human newborn (15, 16) 
METHODS

Rats and experimental protocols
Pregnant Sprague-Dawley rats were obtained from ZivicMiller Laboratories (Allison Park, PA) on day 15 or 16 of gestation. They were housed in individual cages, and on day 16 of GA they were given tap water ad lib. with 0, 1, 2, 5, and 20 mg MMI/100 ml water (1-, 2-, 5-, and 20-mg-MMI groups). This regimen was maintained throughout the nursing period (up to 4 wk), at which time control rats and some of the litters receiving the lowest concentration of MMI had weaned, but were kept in the same cage with MMI-containing water. Within the first 24-48 h after birth, litters were made nine to eleven rats each by redistribution of the pups within dose groups; subsequently the number of rats per litter was kept as nearly equal as possible. Because several litters with the same treatment were run simultaneously, it was always possible to redistribute the pups and make up the groups from two to three litters for each experiment. However, due to a significant mortality rate (three to five rats/litter in 4 wk), and in order to examine the same litters through the 4-wk period, experimental groups were limited to four to five rats. Unless otherwise stated, the variables analyzed in a given experiment were all measured in the same pups. Within these MMI concentration ranges the dams did not restrict their food and water intake (40-70 ml/d). A number of pilot experiments were performed to determine whether the maternal thyroid status influenced either the nutritional condition or the thyroid status of the offspring. Mothers treated with the highest concentration of MMI received T3 simultaneously (0.2 ,g/ml) in drinking water containing 0.01% bovine serum albumin (BSA). At age 3 wk these pups weighed 29±4 g and their serum T3 was 0.09±0.03 ng/ml as compared with 29±4 g and 0.16±0.08 ng/ml in the pups of mothers not receiving the hormone (n = 5). The mothers' serum T3 concentrations were 0.40 and <0.03 ng/ ml, respectively. In other experiments, the 20-mg-MMItreated dams were implanted with an osmotic minipump (Alza Corp., Palo Alto, CA) to deliver .500 ng T3/100 g body weight (bw)/d; the minipump was replaced at 14 d as indicated by the manufacturer. At 3 wk, T3-treated mothers had a serum T3 of 2.5 ng/ml as compared with <0.03 in the T3-untreated dams. The pups weighed 33±1 and 35±2 g and their serum T3 concentrations were 0.16±0.06 and 0.17±0.08
Brain Adaptation to Congenital Hypothyroidism ng/ml, respectively (n = 5). Finally, the stomachs of the pups, usually full of milk, were removed at death and found to weigh 1.03±0.41 g (n = 7) and 1.15±0.7 g (n = 8) in controls and MMI-treated litters, respectively, at age 2 wk. These results indicated there was no significant effect of maternal thyroid status on the pups.
The pups were weighed only on the day of the experiment. They were killed either by decapitation or by aortic exsanguination if radioisotopes had been injected (see below). Cx was removed in situ with the aid of a fine spatula; it was usually contaminated with some white matter but basal ganglia were excluded. Between 600 mg (2 wk) and 900 mg (4 wk) of tissue was collected. Except occasionally at age 2 wk, there was no difference between the amount of tissue collected from control and from MMI-treated rats. The liver was removed almost in toto yielding between 0.7 and 1.5 g of tissue, depending on the age and on the thyroid status of the pups. Both tissues were immediately homogenized in four volumes of 0.32 M sucrose, 10 mM Hepes pH 7.0, and 1 mM dithiothreitol (DTT) (liver) or 10 mM DTT (cortex) (17) . They were then either snap frozen in dry ice-acetone or kept in ice-cold water for assay within 1-2 h of death, as indicated below. All assays of a given age group were performed simultaneously. 250 Ml of 10% ice-cold TCA, followed by 2 ml of 95% ethanol. Tubes were centrifuged at -2,000g for 10 min and the optical density determined at 500 nm. The reaction was linear with time up to 20 min, provided the optical density was <0.600. The optical density of the blank tubes varied between 0.02 and 0.05, and the samples between 0.15 and 0.35. As to the effect of MMI-treatment, both methods gave the same results, i.e., the 20-mg-MMI pups showed 30-50% lower values than the controls (see Results).
Aspartic transaminase. The assay was performed using crude homogenates; the method used was based on that designed by Karmen (20) , but slightly modified. The homogenate was pretreated with deoxycholate to release the latent enzyme (21) . Usually 0.4 ml of one-fifth homogenate was incubated for 20 min at 37°C with 0.15 ml of 4.25% Na deoxycholate, and it was subsequently diluted 1:40 with the reaction buffer (0.01 M sodium phosphate, pH 7.4). The reaction mixture contained 4.2 ml of buffer; 0.6 ml of 0.2 M Na a-ketoglutarate, pH 7.4; 0.3 ml 500 U/ml malic dehydrogenase (in phosphate buffer); and 1.2 ml diluted homogenate. Sets of four tubes were immersed in a water bath at 30°C and preincubated for 5 min, and then 0.6 ml of 1 mg/ ml NADH solution was added, rapidly followed by 1. (4, 5) . This method of expressing the results has been shown to be more sensitive (4, 5) and allows a better assessment of the enzyme on a per cell basis.
Hepatic mitochondrial a-glycerophosphate dehydrogenase (a-GPD). Liver homogenate was made 1:10 with 0.32 M sucrose and 1 mM MgC92, and then centrifuged at 800 g for 10 min. The supernatant was centrifuged at 10,000 g for 10 min and the pellet was washed once in 0. 32 In vivo studies
To assess the capacity of both the cortex and liver to generate T3 from T4 in vivo, small doses of radiolabeled T4 were injected intravenously. In the first of. these experiments 131I-T4, 600 ng/100 g bw (sp act -5800 ,Ci/Ag), was injected and animals were killed 16 in the serum were measured by a combined affinity and paper chromatography method described previously (28) . Serum ['25I]T4 was measured by descending paper chromatography of whole serum (29) or by TCA precipitation. lodothyronines were extracted from crude homogenate in butanol saturated with 2 N HCI, usually 0.25 ml homogenate plus 1 ml of butanol HCI, which ensured >80% extraction. The extract was dried under N2 and the iodothyronines resuspended in 50 gl ethanol: 2 N NH40H (99:1) containing 1 mg/ml T4, T3, and NaI. The suspension was applied to 3 -mm Whatman paper (Whatman Inc., Clifton, NJ) and developed as described (29) .
Other procedures T4, T3, and TSH were assayed in serum by methods previously reported (30) (31) (32) . T4 and T3 from hypothyroid rats were measured using hormone-stripped serum from hypothyroid rats in the standard curves. Hypothyroid rat serum decreases the slope of the displacement curve in such a way that samples with low T3 values are overestimated if read using standard curves containing hormone-free serum from euthyroid rats.
Results are expressed as mean±SD or range. Statistical analyses included t tests, both paired and unpaired, arid regression analyses. The latter were performed using a Hewlett-Packard 9815A calculator (Hewlett-Packard Co., Palo Alto, CA) by evaluating the best fit of the data to a number of linear and nonlinear mathematical models contained in the software from the manufacturer. This was done merely to facilitate the description of the data. The interpretation of the better fit to one model as compared with another is beyond the scope of this work. Similarly, we intend no implication as to whether the relationships implied by the formulas would predict the changes in y beyond the observed ranges of the variable x. As to the comparisons between the mean of a given variable obtained, with a given dose of MMI and that of the control group within an experiment, i.e., at one particular age (Table I, Fig. 1 ), we used a per comparison approach (33) rather than a multiple comparison test (34) . The rationale for this statistical treatment is that we do not attach any significance to each dose of MMI, which was arbitrarily chosen to induce graded hypothyroidism, but to the serum thyroid hormone concentrations induced by this treatment and their relationship to the biological responses analyzed. Because serum levels of T3 and T4 varied widely both within and between treatment groups, we further evaluated the data in terms of the individual hormone results, regardless of the MMI dose that induced them.
RESULTS
Effect of MMI given to the mothers on serum hormone levels of the offspring (Tables I and II and Fig.  1 ). Serum T4 in control pups did not change with age, but serum T3 increased between 2 and 3 wk to a plateau as has been described (15) ( Table I) . Such a pattern was observed also in the 1-mg-MMI group (P < 0.01), but was not evident in the pups exposed to higher concentrations of MMI. The various concentrations of MMI produced a wide spectrum of serum T4 and T3 concentrations even within a given group, probably reflecting individual variations in the MMI intake through the milk, the susceptibility of the thyroid to the drug, and the response of the pituitary thyroid axis, etc. (compare the standard deviations of MMI-treated pups with those of the control groups). The 1-mg-MMI group serum T3 was not different from controls at any age, but the 5-mg-MMI group serum T3 became significantly lower at 4 wk. At all ages, the 20-mg-MMI group had significantly lower serum T3 concentrations than the controls. Serum T4 was always decreased by MMI except in the 1-mg-MMI group at 2 wk, where there was an overlap with the controls. Fig. 1 shows the relationship between the individual serum concentrations of both iodothyronines and gives a better idea of the variation in the response to MMI. The data were best fit to a model where [T3] = a [T4t. At all ages, but especially at 2 and 3 wk, serum T3 fell below the normal range only when T4 was very low. At 3 wk and, to some extent, at 4 wk, supranormal levels of T3 (>0.65 ng/ml) were often found with normal or low serum T4 values.
Because of the short supply of serum, TSH was measured in a limited number of samples. Table II Data represent mean±SD. o MMI was given to pregnant rats in drinking water from day 16 of gestation throughout the nursing period as described in Methods.
The drug concentration is given as mg/100 ml. Each set of T4 and T3 values represents the mean±SD of four pups.
4 P value when compared with age-matched controls. § P < 0.01 when compared with 2-wk-old rats receiving same treatment. P < 0.005 when compared with 2-wk-old rats receiving same treatment.
(P < 0.025 compared with 20-mg-MMI group) and the same trend was shown by the 2-mg-MMl group. As shown in Fig. 1 , many rats in these groups had elevated levels of T3. However, the lack of measurements of T4, T3, and TSH in the same samples precludes further analysis.
Effect of different MMI regimens on neonatal Cx enzyme activities (Fig. 2) . The enzyme activities were measured in tissue samples from the same pups discussed above. At 2 wk, AT, S.D., and ATPase activities were significantly reduced only in the 20-mg-MMI group. At 3 wk, reduced levels of these three enzyme activities were observed in the 5-mg-MMI group as well, and at 4 wk one of the enzymes, AT, was also reduced in the 1-mg-MMI group. Although all these differences from the controls reached statistical significance, the values found in the hypothyroid pups were seldom <60% of the euthyroid controls. The difference observed at 2 wk between the 20-mg-MMI group and the controls, although modest, was quite reproducible, as is evident in Table V (see below) and from several other subsequent experiments not shown.
I 5'D activity responded quite differently to MMI. At 2 wk, both 5-and 20-mg-MMI groups showed a striking 10-13-fold increase in the enzyme activity measured with either substrate, and there was no difference between these two groups. The 1-mg-MMI group showed a modest increase significant only when the enzyme was assayed with rT3 as substrate. At 3 and 4 wk both 5-and 20-mg-MMI groups also showed comparable increases, but the activity was only three-to fivefold that of controls, although at 4 wk we measured onlyrT3 5'-deiodination. The changes in 5'-deiodination of T4 and PTU-insensitive rT3 deiodination as assayed here were identical throughout, with the correlation coefficient of all pairs of such assays equal to 0.991.
Correlation between serum thyroid hormones and the observed changes in the various enzyme activities (Figs. 3, 4A-C) . As indicated above, the various MMI Most of these rats were littermates of those used for experiments 1 (3 wk) and 2 in Table I . e MMI, methimazole concentration (mg/100 ml) in drinking water as described in Methods and Fig. 2 , in the liver the correlation was in the opposite direction and not as high. In liver, normal I 5'D activities were observed in the 2-and 5-mg-MMI group in spite of a reduced serum T4. These rats (diamonds and squares identified with numbers in Fig. 5 ) often had elevated levels of serum T3, whereas those with decreased enzyme activity had both a low serum T4 and T3. Consistent with the data in Fig. 2 Tables III and IV were intended to determine whether the elevated I 5'D activity found in vitro was a reflection of the in vivo capacity of Cx to generate T3 from T4. These experiments were performed in 2-wk-old pups, because at that time the response is maximal.
In the experiment shown in Table III , 600 ng of ['311]T4/100 g bw, approximately one-third of the daily production rate of T4 for 2-wk-old rats (15) , was given to euthyroid and 20-mg-MMI pups 16 h before death. IOP, an inhibitor of I 5'D, was also given to some pups to block in vivo T3 formation. The cortex:serum ratio of ['31I]T4 was greater in the euthyroid than in the 20-mg-MMI pups (P < 0.001), and in both it was significantly increased by IOP to similar values (P < 0.001). The cortex:serum ratio for ['31I]T3 was increased threefold in 20-mg-MMI pups relative to controls (P < 0.001), and this difference was abolished by IOP. Because of these differences, the T3:T4 ratio in hypothyroid cortex was 10-fold that in euthyroid rats. This difference in T3:T4 ratio was also abolished by IOP. Using the specific activity of the injected T4, the concentrations of T4 and T3 derived from the T4 dose were calculated. The tissue T4 concentration was threefold greater in the euthyroid controls than in the 20-mg-MMI group (P < 0.001), and in both groups IOP treatment increased the concentration of T4 severalfold (P < 0.001). Despite the reduced concentration of T4 in the cortex of the hypothyroid pups, the concentration of T3 derived from T4 [T3 (T4)] was 3.3-fold higher in the 20-mg-MMI rats than in the controls (P < 0.001). This concentration of T3 is about three times the reported T3 concentration of 1.2 ng/g in adult euthyroid rat cerebral cortex (35) . At the time of death, the serum concentration of T4 derived from the dose was 21.4±1.2 ng/ml in the control group and 17±1.9 ng/ml in the MMI-treated rats (P < 0.001). However, these figures may be -25% overestimated since they are based on serum TCA-precipitable-'311 (see below).
In a second experiment we evaluated whether the T3 acutely generated from T4 would have a biological effect. IOP was used for the same purpose as in the previous experiment. Because in that experiment, the 1116
J. E. Silva and P. R. Larsen Tables  IV and V . At 24 h only a minimal increase in serum T4 of 2.6-2.7 ng/ml was observed in both euthyroid and MMI-treated rats. The increment in T4 in the Cx of euthyroid rats was 0.34 ng/g, -30% of the normal endogenous T4 content (35, 36) , but in the hypothyroid pups this increment was only 0.06 ng/g. This, and the large increments in cortex T4 induced by IOP, indicate that the lower cortex:serum T4 ratio in hypothyroid pups is due mainly to accelerated T4 degradation in these animals. A similar phenomenon of less magnitude was observed in the liver. The T3 derived from the T4 in serum, cortex, and liver was significantly higher in hypothyroid animals and the difference exceeded that expected from the differences in the dose per unit weight. Due to differences in weight, the hypothyroid rats received a mean of 1.6 times more T4 than the euthyroid pups, but the [251I]T3 was 3.3, 2.5, and 4.6 times higher in the serum, liver, and cortex of the MMI-treated rats than in the euthyroid controls.
The serum [31I]T3 in hypothyroid rats given T4 was 0.23±0.03% of the dose per milliliter, whereas in the euthyroid controls it was 0.13±0.01% of the dose per milliliter (P < 0.001), suggesting a significant, albeit modest, decrease in T3 clearance in the hypothyroid pups. If the 1.6-fold greater body weight of the control pups is taken into consideration, and assuming proportionality between body weight and volume of distribution, differences in fraction removal rate of T3 do not turn out to be a major factor in the observed values of serum [31I]T3 in the T4-treated hypothyroid pups. Furthermore, the cortex:serum ratio of [131I]T3
was not different in any of these groups, indicating that there was no "sequestration" of T3 in the nervous pothyroidism. All three enzyme activities were measured in crude homogenates as described. Symbols and explanations are as for Fig. 1 (Table V) were reduced in all hypothyroid animals compared with the controls (P < 0.001). AT was significantly higher in the 20-ng-MMI group treated with 60 ng of T4 than in any of the other groups of hypothyroid controls. This was the only enzyme that showed a significant increase after T4. This response has been reproduced in several other experiments. IOP blocked this effect of T4 despite the marked increase in serum and tissue T4 that occurred in these animals (Table IV) . This was not a nonspecific effect of IOP because it did not affect the level of the enzyme in hypothyroid pups receiving only tracer [1251]T4 (3 ng) . Liver a-GPD also failed to increase with this small dose of T4, which may be accounted for by the minimal elevation of serum T3 and the long latency of this enzyme to respond to thyroid hormone (37) . DISCUSSION We have recently described the mechanism of the pituitary response to a failing thyroid gland (reviewed in 13). In essence, the decreased serum T4 leads to pituitary hypothyroidism and the ensuing increase in TSH stimulates the thyroid to secrete T3, keeping serum T3 within normal limits until well advanced thyroid failure. The results of the present experiments show that this mechanism is indeed operative in the neonatal rat, because T3 was maintained within normal limits in the face of markedly decreased (<10% of The weight of the animals is given in Table V . IOP, 10 mg/100 g bw, was injected intraperitoneally 40 Table III. § P < 0.01 with respect to A.
T P < 0.005 with respect to A. I P < 0.001 with respect to A. "P < 0.001 with respect to B. normals) serum T4 (Tables I and II , Fig. 1 (38, 39) . Because of the residual thyroid tissue in these infants, serum T4 is variably reduced and often serum T3 is normal. In another common cause of congenital thyroid impairment, iodine deficiency, normal cord serum T3, and low T4 are common findings (40, 41) . Therefore, the experimental model used in the present studies has distinct parallels to human disease.
The possibility that MMI, by a mechanism other than the well known antithyroid effect, may account for our findings is remote. In Methods we have presented evidence that the drug does not affect the enzyme assays nor can it reduce the enzyme levels in surgically thyroidectomized rats. The better correlation of our results with serum thyroid hormone levels than with the dose of MMI and the effect of T4 treatBrain Adaptation to Congenital Hypothyroidism ment on the enzymes (Table V) in MMI-treated pups point in the same direction. In addition, the levels of all three enzymes have been shown to be reduced to an even greater extent in 1311-induced neonatal hypothyroidism (4, 5) . Although the thyroid hormone plasma levels were not given in those reports one would assume that 131I can induce a more severe form of hypothyroidism. At the same time, those results (4, 5) indicate that qualitatively similar data are obtainable in hypothyroidism induced by other means.
Effect of the various MMI doses on cerebral enzymes. In spite of the reduced levels of serum T4 in virtually all MMI-treated pups, at 2 wk only the 20-mg-MMI group showed biochemical evidence of hypothyroidism in the cortex with decreased AT, S.D., and ATPase (Fig. 2) , whereas when the animals increased in age, and also in the duration of MMI exposure, modest tissue hypothyroidism was observed after exposure to lower quantities of MMI. In all these situations, the changes observed in these enzymes were modest, contrasting with the concomitant marked increases of the I 5'D in the MMI-treated animals. The 10-fold increase in I 5'D observed at 2 wk in the pups receiving the highest doses of MMI compared with the three-to fivefold increase in the pups on the same MMI dose later on (Figs. 2, 3) , and the relationship between the levels of AT, S.D., and ATPase and serum T4 and T3 at different ages, all suggest that the increased I 5'D activity in response to hypothyroidism is of high adaptive value. Furthermore, one can speculate that the success of such a mechanism in maintaining cerebral cortical euthyroidism will presumably depend on at least two, though perhaps more, factors. The first is the quantity of tissue substrate (T4) available and the second, the magnitude of the increase in I 5'D activity achievable. Thus, in the 2-wk-old rats, normal AT, S.D., and ATPase activities are seen in the 5-mg-MMI but the 20-mg-MMI animals show hypothyroid responses. Because the I 5'D is increased 10- fold in both, it would appear that inadequate quantities of T4 are available in the latter. Although, on average, the serum T4 was not statistically lower in 20-mg-MMI rats than in 5-mg-MMI at 2 wk (Table I) , it tended to be higher in the latter (Fig. 1), Table IV add support to and expand the information provided by the above findings. In this experiment, the injected T4 dose was only 150-300 ng/100 g bw, and at 24 h this was associated with an insignificant increase in the serum T4.
The concomitant injection in these pups of ['31I]T3 allowed estimates of the fraction of the tissue T3 increments that could be attributed to local T4 to T3 conversion using the approach that we have previously described (6, 12) . Also, we could determine how much of the observed differences in tissue ['25I]T3 (T4) can be accounted for by changes in T3 distribution and degradation. As would be expected from our studies in adult rats (17, 42) , most of the ['25I]T3 in the Cx could be attributed to T4 and T3 conversion occurring within the Cx in euthyroid pups. In both euthyroid and hypothyroid pups, 75% of the newly formed T3 (T4) found at 24 h in the Cx was produced locally. This may be disturbing at the first glance because the 10-fold increase in I 5'D would allow one to expect a greater relative contribution of the local source. We interpret the finding to be purely coincidental. Thus, these figures have been obtained 24 h after an intravenous pulse of T4, and in Table IV it is apparent that the concentration of T4 has decreased markedly at that time in the cortex of these hypothyroid pups, i.e., 0.06±0.01 ng/g compared with 0.34±0.06 ng/g in the controls. On the other hand, because the serum T3 (T4) was higher in hypothyroid pups by roughly the same factor as the total Cx T3 (T4) was, and because the tissue:plasma ratio of ['311]T3 was not different, the serum contribution was higher in hypothyroid pups than in the controls by the same factor as the tissue T3 (T4) was elevated. The relative contribution of local as compared with the serum source to cortex T3 found under these conditions does not represent the steadystate conditions where endogenous concentrations of T4 and T3 must be taken'into consideration.
The higher serum T3 (T4) in hypothyroid pups may be due to two factors. One is decreased T3 degradation, as suggested by the higher concentration of [131I]T3, 0.23±0.01% of the dose per milliliter in hypothyroid pups as opposed to 0.13±0.01% in controls. However, because the hypothyroid animals were smaller by approximately the same factor, the difference' in serum concentration is not readily accounted for by de- creased fractional T3 degradation. Furthermore, assuming that the difference is totally due to reduced volume of distribution, the overall rate of serum T4 to T3 conversion is at least the same in hypothyroid neonatal rats as in euthyroid pups. At any rate, regardless of the factor(s) responsible for the higher serum T3 (T4) in the hypothyroid neonates, the cortex:serum ratio of ['31I]T3 was not affected by the thyroid status, indicating that differences in T3 clearance are equally reflected in both compartments.
Comparison between liver and cortex I 5'D and T3 generation. In this context, it is interesting that the liver I 5'D showed a change in opposite direction to the cortex with hypothyroidism (Fig. 5 ). In agreement with this in vitro finding, the increased concentration of newly formed T3 (T4) found in this tissue in MMItreated pups is accounted for by the observed higher serum T3 (T4). Two important implications can be derived from these findings: (a) the liver is not as important a source of T3 in neonatal hypothyroid rats as it is in the euthyroid adult rat or even the euthyroid neonate, and (b) the increased I 5'D observed in the cortex of the hypothyroid pups is physiologically relevant. Thus, in (6, 12, 13, 17) . An important question raised by these findings is the signal that stimulates the increase in I 5'D, because based on the above hypothesis, one woud assume that the cerebral cortical T3 concentration is normal or near normal when this compensation has occurred. Fig. 3 demonstrates how closely related the activity of the I 5'D is to the concentration of T4 in the serum and how poorly it relates to the level of serum T3 despite the fact that there is an obvious relationship between concentrations of serum T3 and T4 in these MMItreated pups (Fig. 1) . The activity of the enzyme thus seems to be governed by the level of serum T4 rather than by the T3 generated from it. At present, we do not know how the enzyme is regulated by thyroid hormones, though other data from our laboratory indicate that this increase in activity is due to an increase in the maximum velocity (VYax) as opposed to the Michaelis constant (Km) of the enzyme (10, 24) . It is also not clear whether this Vmax increase represents an activation of latent enzyme units or changes in the synthetic rate of the enzyme. It is possible, given the marked heterogeneity of cerebral cortical tissue, that cells responding to the change in T4 with an increase in I 5'D are different from those that are reflected by the activities of AT, S.D., and ATPase. The possibility must also be raised that the enzyme is regulated by the level of T4 directly, without the necessity for the generation of T3 and the subsequent interaction of this T3 with the nuclear receptor. Whatever the answer to the questions posed by these data, the findings suggest that the intracellular T3 concentration is carefully regulated in the developing brain. It is most interesting that in the Cx the capacity to respond to hypothyroidism appears maximal during the time when the maturation rate is highest and the normal adaptive feedback regulation of the pituitary-thyroid axis is not completely developed (2, 3, 15) .
In terms of the clinical implications of these findings, it would appear important to evaluate the neurological and psychological outcome of the congenitally hypothyroid infant in terms of the serum concentrations of T4 rather than of T3. That the laudable outcome of treatment of infants with congenital hypothyroidism discovered by screening is so much better than has been reported in the literature before the time of screening was begun (43) may be due to the fact that clinically detected congenital hypothyroidism is likely to be more severe than that discovered by the sensitive screening process. The data at 3 and 4 wk in these rats suggest that this compensatory mechanism cannot protect the Cx indefinitely. This is consistent with the fact that earlier intervention with thyroid hormone is consistently more successful in preventing irreversible mental retardation in the congenitally hypothyroid infant (44) .
